Clinical Handbook of Psychotropic Drugs for Children & Adolescents

Table of Contents Psychiatric Disorders in Children and Adolescents Attention-Deficit/Hyperactivity Disorder (ADHD) Major Depressive Disorder (MDD) Disruptive Mood Dysregulation Disorder (DMDD) Bipolar Disorder (BD) Schizophrenia ANXIETY DISORDERS Separation Anxiety Disorder Generalized Anxiety Disorder (GAD) Social Anxiety Disorder Panic Disorder Specific Phobia Obsessive-Compulsive Disorder (OCD) TRAUMA- AND STRESSOR-RELATED DISORDERS Posttraumatic Stress Disorder (PTSD) TIC DISORDERS Tourette's Disorder Autism Spectrum Disorder (ASD) DISRUPTIVE, IMPULSE-CONTROL, AND CONDUCT DISORDERS Conduct Disorder (CD) Oppositional Defiant Disorder (ODD) Drugs for ADHD Psychostimulants Atomoxetine Comparison of Drugs for ADHD α2 Agonists Augmentation Strategies in ADHD Antidepressants Selective Serotonin Reuptake Inhibitors (SSRI) Norepinephrine Dopamine Reuptake Inhibitor (NDRI) Serotonin Norepinephrine Reuptake Inhibitor (SNRI) Serotonin-2 Antagonists/Reuptake Inhibitors (SARI) Serotonin-1A Agonist/Serotonin Reuptake Inhibitor Noradrenergic/Specific Serotonergic Antidepressants (NaSSA) Nonselective Cyclic Antidepressants Monoamine Oxidase Inhibitors Reversible Inhibitor of MAO-A (RIMA) Irreversible Monoamine Oxidase (A&B) Inhibitors (MAOIs) Effects of Antidepressants on Neurotransmitters/Receptors Pharmacological Effects of Antidepressants on Neurotransmitters/Receptors Frequency of Adverse Reactions to Antidepressants at Therapeutic Doses Antidepressant Doses and Pharmacokinetics Switching Antidepressants Antidepressant Augmentation Strategies Electroconvulsive Therapy (ECT) Antipsychotics "Second-Generation" Antipsychotics/SGAs "Third-Generation" Antipsychotic/TGA "First-Generation" Antipsychotics/FGAs Effects of Antipsychotics on Neurotransmitters/Receptors Pharmacological Effects of Antipsychotics on Neurotransmitters/Receptors Frequency (%) of Adverse Reactions to Antipsychotics at Therapeutic Doses Antipsychotic Doses and Pharmacokinetics (Oral and Short-

"A 'must-have' for those prescribing psychotropic medications in children and adolescents. It remains by far the most user-friendly and comprehensive handbook available for prescribers, teachers, students, and others working or interested in the field of child and adolescent psychopharmacology." (Pieter Joost van Wattum, MD, MA, in Journal of Clinical Psychiatry, Vol. 70, p. 301) "If you see children who are placed on psychotropic medications, this books clearly falls into your 'must-have' category." (J.C. Courtney in Child Neuropsychology, Vol. 11, p. 311) "Provides the busy clinician with all the information that is essential for those prescribing a psychotropic drug to a child or adolescent....Very 'user friendly'...Highly recommended to all clinicians that specialize in treating children and adolescents." (B.E. Leonard in Human Psychopharmacology, Vol. 20, p. 70) "The main strength of this book is its ability to summarize a large amount of information and make it immediately available at one's fingertips. The clinician needing facts and needing them fast will enjoy the handbook." (S. C. Kowalik in Journal of Child and Adolescent Psychopharmacology, Vol. 15, p. 129) "A practical resource guide for trainees as well as experienced clinicians." (Tanvir Singh & Jeff Wahl in Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 44, p. 606) "Authoritatively and exhaustively compiles currently available information in a user-friendly form. The aim of the Handbook is to be a source of 'fast facts' for the busy clinician...an aim it achieves splendidly." (M. Gittelman, Editor of International Journal of Mental Health) "Well-researched...An essential reference book [that] all professionals should have...Full of indispensable information and data in a sequenced and logical design." (P. Shelley in International Journal of Psychiatric Nursing Research, Vol. 20) "A useful guide for busy clinicians and one that puts pharmacotherapy for child and